This archive contains the following articles listed by volume, issue and page number:
 |
|
|
Volume 2, 1998 Articles |
Title (Click for Details) |
Vol/Issue |
Page |
Essential Truths About HRT |
Vol. 2 No. 1 |
10 |
Interview on HRT: Christiane Northrup, MD, FACOG |
Vol. 2 No. 1 |
12 |
HRT and the Continuing Education of Health Care Professionals |
Vol. 2 No. 1 |
18 |
Estrogen and Breast Cancer: Is There a Link? |
Vol. 2 No. 1 |
21 |
Estrogen in the Treatment and Prevention of Alzheimer's Disease |
Vol. 2 No. 1 |
24 |
Reviews: Books on HRT |
Vol. 2 No. 1 |
30 |
The Formulation and Use of Placebo Dosage Forms in Pharmacy |
Vol. 2 No. 1 |
35 |
Hiring Good People |
Vol. 2 No. 1 |
38 |
Basic Statistical Concepts for Evaluating Pharmaceutical Compounding Literature: Part 2. Confidence Intervals and p Values |
Vol. 2 No. 1 |
42 |
Estradiol 1-mg Vaginal Suppositories |
Vol. 2 No. 1 |
48 |
Estradiol Topical Gel |
Vol. 2 No. 1 |
49 |
Estradiol Vaginal Cream (0.2%) |
Vol. 2 No. 1 |
50 |
Estradiol Vaginal Gel (0.2%) |
Vol. 2 No. 1 |
51 |
Methyltestosterone 6-mg/g Gel |
Vol. 2 No. 1 |
52 |
Progesterone Enema 100- and 200-mg/mL |
Vol. 2 No. 1 |
53 |
Progesterone-Estradiol-Testosterone in Oil Capsules |
Vol. 2 No. 1 |
54 |
Progesterone in Oil Capsules |
Vol. 2 No. 1 |
55 |
Progesterone Nasal Spray (2%) |
Vol. 2 No. 1 |
56 |
Progesterone Oral Suspension (40-mg/mL) |
Vol. 2 No. 1 |
57 |
Progesterone 3% Vaginal Gel |
Vol. 2 No. 1 |
58 |
Progesterone Troches (100-mg, Soft) |
Vol. 2 No. 1 |
59 |
Progesterone Troches (300-mg, Hard) |
Vol. 2 No. 1 |
60 |
Progesterone Troches (400-mg, Soft) |
Vol. 2 No. 1 |
61 |
Progesterone 200-mg Buccal Tablets |
Vol. 2 No. 1 |
62 |
Progesterone 200-mg Linguets (Soft) |
Vol. 2 No. 1 |
63 |
Progesterone Vaginal Cream (5%) |
Vol. 2 No. 1 |
64 |
Progesterone Vaginal Suppositories (Fatty Acid Base) |
Vol. 2 No. 1 |
65 |
Progesterone Vaginal Suppositories (Polyethylene Glycol Bases) |
Vol. 2 No. 1 |
66 |
Testosterone Propionate Gel |
Vol. 2 No. 1 |
67 |
Testosterone Propionate 100-mg/6 mL Cream |
Vol. 2 No. 1 |
68 |
Testosterone Propionate 2% Ointment |
Vol. 2 No. 1 |
69 |
Testosterone 0.625-mg Troches |
Vol. 2 No. 1 |
70 |
Extemporaneous Lozenge Formulations |
Vol. 2 No. 1 |
71 |
Silicates: Bentonite, Magnesium Aluminum Silicate, Silica Gel and Colloidal Silicon Dioxide - , Featured Excipient: |
Vol. 2 No. 1 |
73 |
Calculations |
Vol. 2 No. 1 |
74 |
Glasnapp's Rule |
Vol. 2 No. 1 |
75 |
The pH Value of Urea Solutions in Purified Water |
Vol. 2 No. 1 |
76 |
Standard Operating Procedure for Particulate Testing for Sterile Products |
Vol. 2 No. 1 |
78 |
Physical Compatibility and Chemical Stability of Atracurium Besylate and Midazolam Hydrochloride during Intravenous Coinfusion |
Vol. 2 No. 1 |
79 |
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane |
Vol. 2 No. 1 |
83 |
Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base |
Vol. 2 No. 1 |
89 |
PostScription: Independent Pharmacy: Alive and Well |
Vol. 2 No. 1 |
96 |
Compounding for Pain Management |
Vol. 2 No. 2 |
104 |
Opioids for Noncancer Pain: From Controversy to Consensus |
Vol. 2 No. 2 |
106 |
Phonophoresis with Hydrocortisone 10% in a Highly Viscous Complant Base |
Vol. 2 No. 2 |
110 |
Managing Pain in the Terminally Ill |
Vol. 2 No. 2 |
111 |
The Symptom Relief Kit for Hospice Patients |
Vol. 2 No. 2 |
116 |
Dextromethorphan Hydrobromide and Opioid Tolerance: A Compounding Opportunity for Pharmacists with Chronic Pain Patients |
Vol. 2 No. 2 |
118 |
Profile of a Practice/Patient Handout: DHE Nasal Spray |
Vol. 2 No. 2 |
120 |
Clinical Application of Ketamine Ointment in the Treatment of Sympathetically Maintained Pain |
Vol. 2 No. 2 |
122 |
Firing an Employee - Without Getting Burned |
Vol. 2 No. 2 |
130 |
Problems with Third-Party Payments for Compounded Prescriptions |
Vol. 2 No. 2 |
134 |
The pH Value of Common Household Products Using Meters, Papers and Sticks |
Vol. 2 No. 2 |
137 |
Accuracy in Prescriptions Compounded by Pharmacy Students |
Vol. 2 No. 2 |
139 |
Analgesic Medication Stick |
Vol. 2 No. 2 |
144 |
Buprenorphine HCl 150-mcg/100 mcL Nasal Spray |
Vol. 2 No. 2 |
145 |
Capsaicin 0.05% Topical Gel |
Vol. 2 No. 2 |
146 |
Dexamethasone Sodium Phosphate 1-mg/mL for Iontophoresis |
Vol. 2 No. 2 |
147 |
Dextromethorphan Hydrobromide 30-mg and Morphine Sulfate 10-mg Capsules |
Vol. 2 No. 2 |
148 |
Dihydroergotamine Mesylate 2.5-mg/mL Nasal Spray |
Vol. 2 No. 2 |
149 |
Dihydroergotamine Mesylate 1-mg Troches |
Vol. 2 No. 2 |
150 |
Ergotamine Tartrate, Caffeine, Hyoscyamine Sulfate and Pentobarbital Sodium Suppositories |
Vol. 2 No. 2 |
151 |
Fentanyl 50-mcg Chewable Gummy Gels |
Vol. 2 No. 2 |
152 |
Fentanyl 300-mcg/6-mL Inhalation |
Vol. 2 No. 2 |
153 |
Ketoprofen 10%, Cyclobenzaprine 1% and Lidocaine 5% in Poloxamer Lecithin Organogel |
Vol. 2 No. 2 |
154 |
Lidocaine 30% Lip Balm |
Vol. 2 No. 2 |
155 |
Meperidine HCl 50-mg/mL Nasal Solution |
Vol. 2 No. 2 |
156 |
Morphine Sulfate 25-mg Troche |
Vol. 2 No. 2 |
157 |
Sumatriptan 5-mg/mL Oral Liquid |
Vol. 2 No. 2 |
158 |
Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel |
Vol. 2 No. 2 |
159 |
Vehicles for Compounding Oral Liquids: Some Practical Considerations |
Vol. 2 No. 2 |
160 |
Silicates: Attapulgite, Kaolin, Kieselguhr, Magnesium Trisilicate, Pumice, Talc - Featured Excipient: |
Vol. 2 No. 2 |
162 |
Calculations |
Vol. 2 No. 2 |
164 |
Class A Prescription Torsion Balance Performance Tests |
Vol. 2 No. 2 |
166 |
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection |
Vol. 2 No. 2 |
168 |
Stability of Indomethacin in 0.9% Sodium Chloride Injection |
Vol. 2 No. 2 |
170 |
PostScription: Hey, Let's Work Together! |
Vol. 2 No. 2 |
176 |
Compounding Ophthalmic Preparations |
Vol. 2 No. 3 |
184 |
Isotonic Sodium Chloride Solution Vehicle for Ophthalmics |
Vol. 2 No. 3 |
188 |
Boric Acid Solution Vehicle for Ophthalmic Preparations |
Vol. 2 No. 3 |
188 |
Boric Acid Solution Vehicle without Benzalkonium Chloride for Ophthmalic Preparations |
Vol. 2 No. 3 |
188 |
Phosphate Buffer System Vehicle for Ophthalmics |
Vol. 2 No. 3 |
188 |
Ophthalmic Compounding: Techniques for Achieving Sterility |
Vol. 2 No. 3 |
189 |
Buffer Solutions for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Palitzsch Buffer Acid Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Sodium Acetate-Boric Acid-Alkaline Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Sorensen's Modified Phosphate Buffer-Acid Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Sorensen's Modified Phosphate Buffer- Alkaline Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Atkins and Pantin Buffer Solution for Ophthalmic Preparations - Acid Stock Solution |
Vol. 2 No. 3 |
190 |
Atkins and Pantin Buffer Solution for Ophthalmic Preparations - Alkaline Stock Solution |
Vol. 2 No. 3 |
190 |
Feldman Buffer for Ophthalmic Preparations-Acid Stock Solution |
Vol. 2 No. 3 |
190 |
Feldman Buffer for Ophthalmic Preparations-Alkaline Stock Solution |
Vol. 2 No. 3 |
190 |
Palitzsch Buffer Alkaline Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Sodium Acetate-Boric Acid-Acid Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Gilford Ophthalmic Buffer-Acid Stock Solution |
Vol. 2 No. 3 |
191 |
Gilford Ophthalmic Buffer-Alkaline Stock Solution |
Vol. 2 No. 3 |
191 |
Anatomy of the Eye |
Vol. 2 No. 3 |
191 |
Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations |
Vol. 2 No. 3 |
192 |
Ophthalmic Solutions in Cataract Surgery |
Vol. 2 No. 3 |
196 |
A Glimpse Into the Future |
Vol. 2 No. 3 |
203 |
An Eye to Success |
Vol. 2 No. 3 |
205 |
Veterinary Dexamethasone 0.1% Ophthalmic Ointment |
Vol. 2 No. 3 |
206 |
Veterinary 2-deoxy-D-glucose Ophthalmic Ointment |
Vol. 2 No. 3 |
206 |
Ophthalmic Compounding for Animals - Equine Ophthalmic Ointments and Treatment of Epithelial Calcification of the Cornea with EDTA 1% |
Vol. 2 No. 3 |
206 |
Eyecups: The Beginning of Eye Irrigation and Treatment |
Vol. 2 No. 3 |
208 |
Nutraceuticals: New Opportunities for Pharmacists |
Vol. 2 No. 3 |
212 |
An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate |
Vol. 2 No. 3 |
214 |
Basic Statistical Concepts for Evaluating the Pharmaceutical Compounding Literature: Part 4. Student's t-test and One-way Analysis of Variance |
Vol. 2 No. 3 |
216 |
Profile of a Practice: Office Practice Facilitates Compounding and Patient Counseling |
Vol. 2 No. 3 |
219 |
Acetylcysteine 15% Ophthalmic Solution |
Vol. 2 No. 3 |
222 |
Amphotericin B 2-mg/mL Ophthalmic Solution |
Vol. 2 No. 3 |
223 |
Ascorbic Acid 10% Ophthalmic Solution |
Vol. 2 No. 3 |
224 |
Calcium Gluconate 1% Ophthalmic Irrigation Solution |
Vol. 2 No. 3 |
225 |
Cyclosporine 2% Ophthalmic Solution |
Vol. 2 No. 3 |
226 |
Dexamethasone Sodium Phosphate 0.05% Ophthalmic Ointment |
Vol. 2 No. 3 |
227 |
Fluconazole 0.2% Ophthalmic Solution |
Vol. 2 No. 3 |
228 |
Fortified Gentamicin Ophthalmic Solution |
Vol. 2 No. 3 |
229 |
Glucose 40% Ophthalmic Ointment |
Vol. 2 No. 3 |
230 |
Idoxuridine 0.5% Ophthalmic Ointment |
Vol. 2 No. 3 |
231 |
Idoxuridine 0.1% Ophthalmic Solution |
Vol. 2 No. 3 |
232 |
Lissamine Green 0.5% Ophthalmic Solution |
Vol. 2 No. 3 |
233 |
Ophthalmic Lubricant |
Vol. 2 No. 3 |
234 |
Rose Bengal 1% Ophthalmic Solution |
Vol. 2 No. 3 |
235 |
Vancomycin 25-mg/mL Ophthalmic Solution |
Vol. 2 No. 3 |
236 |
Edetic Acid and Its Salts, Featured Excipient: |
Vol. 2 No. 3 |
237 |
Making Capsules Using a Solid Oral Dosage Form of a Different Strength |
Vol. 2 No. 3 |
240 |
Calculations |
Vol. 2 No. 3 |
241 |
General Aseptic Procedures Used at a Laminar Airflow Workbench |
Vol. 2 No. 3 |
242 |
Paclitaxel Compatibility with IV Express Filter Unit |
Vol. 2 No. 3 |
243 |
Stability of Milrinone Lactate in 5% Dextrose Injection and 0.9% Sodium Chloride Injection at Concentrations of 400, 600, 800 mcg/mL |
Vol. 2 No. 3 |
246 |
Sorption of Benzalkonium Chloride to Various Filters Used in Ophthalmics |
Vol. 2 No. 3 |
249 |
Compounding Dermatological Products |
Vol. 2 No. 4 |
260 |
Case Studies: Treating Dermatological Patients with Compounded Products |
Vol. 2 No. 4 |
266 |
Malathion 0.5% Lotion |
Vol. 2 No. 4 |
268 |
Malathion Topical Lotion: Therapy for Resistant Head Lice |
Vol. 2 No. 4 |
268 |
Treatment of Skin Aging with Topical Estrogens |
Vol. 2 No. 4 |
270 |
Dermatological Compounds from the Caribbean |
Vol. 2 No. 4 |
276 |
Antipruritic Cream (Same as Rash Cream) |
Vol. 2 No. 4 |
276 |
Anesthetic Lotion ( "Betacaine" ) |
Vol. 2 No. 4 |
277 |
Gentamicin- Betamethasone Otic ( " Gentasone" ) |
Vol. 2 No. 4 |
277 |
Nail Fungus Solution |
Vol. 2 No. 4 |
277 |
Swim Ear Drops ( "In Your Ear" ) |
Vol. 2 No. 4 |
277 |
Antipruritus Suspension (Stop Itch) |
Vol. 2 No. 4 |
277 |
Sunburn Lotion ("Soothe") |
Vol. 2 No. 4 |
278 |
Acyclovir with Lidocaine and Sunscreen Stick ( Herpes Ointment ) |
Vol. 2 No. 4 |
278 |
Lip Sunscreen and Protectant |
Vol. 2 No. 4 |
278 |
The Rewards of Treating Decubitus Ulcers |
Vol. 2 No. 4 |
282 |
Decubitus Ulcer Cream |
Vol. 2 No. 4 |
282 |
Tea Tree Oil |
Vol. 2 No. 4 |
284 |
Third Party Contracts and the Compounding Pharmacy |
Vol. 2 No. 4 |
286 |
Mailing and Shipping Medication: Challenges and Solutions |
Vol. 2 No. 4 |
288 |
Benzocaine 2% Anesthetic Gel |
Vol. 2 No. 4 |
296 |
Bleaching Cream |
Vol. 2 No. 4 |
297 |
Cocaine-Phenol-Tannic Acid Ointment |
Vol. 2 No. 4 |
298 |
Fluconazole in Dimethyl Sulfoxide |
Vol. 2 No. 4 |
299 |
Fluorouracil 5% Topical Stick |
Vol. 2 No. 4 |
300 |
Medicated Summer Gel |
Vol. 2 No. 4 |
301 |
Nicotinamide 4% Topical Gel |
Vol. 2 No. 4 |
302 |
1-2-3 Preparations Paste/Cream/Modified Cream |
Vol. 2 No. 4 |
303 |
Peeling Solutions |
Vol. 2 No. 4 |
304 |
Psoriasis Ointment |
Vol. 2 No. 4 |
305 |
Polyethylene Glycols, Featured Excipient: |
Vol. 2 No. 4 |
306 |
Standard Operating Procedure for Physical Quality Assessment of Ointments/Creams/Gels |
Vol. 2 No. 4 |
308 |
Calculations |
Vol. 2 No. 4 |
310 |
The Stability of Amphotericin B in a Mixture of Fungizone and Optimoist |
Vol. 2 No. 4 |
311 |
Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form |
Vol. 2 No. 4 |
314 |
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration |
Vol. 2 No. 4 |
318 |
Stability of Lorazepam in 5% Dextrose Injection |
Vol. 2 No. 4 |
322 |
PostScription: Outdated Literature Resources and the Pharmacist |
Vol. 2 No. 4 |
328 |
Compounded Nutritional Solutions - A Market Overview |
Vol. 2 No. 5 |
335 |
Parenteral Nutrition Equipment and Devices |
Vol. 2 No. 5 |
338 |
Catheter Occlusion: Causes and Solutions |
Vol. 2 No. 5 |
342 |
TPN Bulk Compounding from Bulk Drug Substances |
Vol. 2 No. 5 |
347 |
The Feasibility and Benefits of TPN in Horses: A Review of the Findings |
Vol. 2 No. 5 |
351 |
Model Parenteral Nutrition Formulation (Veterinary) |
Vol. 2 No. 5 |
352 |
Required Documentation for Home Infusion Pharmacies - Compounding Records |
Vol. 2 No. 5 |
354 |
Antique and Collectible Mortars and Pestles |
Vol. 2 No. 5 |
360 |
Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids |
Vol. 2 No. 5 |
366 |
Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids |
Vol. 2 No. 5 |
367 |
Pediatric Central Parenteral Nutrition Solution |
Vol. 2 No. 5 |
368 |
Pediatric Central Parenteral Nutrition Solution with Heparin |
Vol. 2 No. 5 |
369 |
Pediatric Peripheral Parenteral Nutrition Solution |
Vol. 2 No. 5 |
370 |
Three-in-One Adult Total Parenteral Nutrition |
Vol. 2 No. 5 |
371 |
Dextrose Injection and Dextrose, Featured Excipient: |
Vol. 2 No. 5 |
372 |
Balances and Weighing Accuracy |
Vol. 2 No. 5 |
376 |
Calculations |
Vol. 2 No. 5 |
378 |
Testing for Bacterial Endotoxins |
Vol. 2 No. 5 |
379 |
Standard Operating Procedure for Quality Assessment of Parenteral Nutrition Products |
Vol. 2 No. 5 |
380 |
Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump |
Vol. 2 No. 5 |
382 |
Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers Solutions |
Vol. 2 No. 5 |
385 |
Ketorolac tromethamine and Ketoprofen suppositories: release profiles and bioavailability of cocoa butter base formula in rabbits |
Vol. 2 No. 5 |
390 |
Stability of Albuterol in Continuous Nebulization |
Vol. 2 No. 5 |
394 |
Environmental Sensitivities: Summary of a Literature Search |
Vol. 2 No. 6 |
407 |
Environmental Sensitivities: Interview with Liliane J. Bartha, MD and Randy Mentzer, RPh |
Vol. 2 No. 6 |
409 |
Latex Allergy: A Brief Summary |
Vol. 2 No. 6 |
411 |
Alternatives for the Lactose-Intolerant Patient |
Vol. 2 No. 6 |
412 |
Warfarin 5-mg Sodium Capsules |
Vol. 2 No. 6 |
413 |
Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists |
Vol. 2 No. 6 |
414 |
Case Reports: Environmental Compounding |
Vol. 2 No. 6 |
417 |
DMPS 250-mg/5-mL Concentration |
Vol. 2 No. 6 |
417 |
Sulfamethoxazole/Trimethoprim Capsule (Preservative Free) 400-mg/80-mg |
Vol. 2 No. 6 |
418 |
Atropine Sulfate, Preservative-Free Solution 13 mcg/drop |
Vol. 2 No. 6 |
418 |
Book Review: Chemical Sensitivity: The Truth About Environmental Illness |
Vol. 2 No. 6 |
419 |
Veterinary Considerations: COPD in Horses |
Vol. 2 No. 6 |
420 |
Treating Patients Allergic to Poison Ivy |
Vol. 2 No. 6 |
421 |
Poison Ivy Extract Injection (10-mcg/mL) |
Vol. 2 No. 6 |
421 |
Introduction to Nuclear Pharmacy |
Vol. 2 No. 6 |
424 |
Physical Requirements for a Nuclear Pharmacy |
Vol. 2 No. 6 |
426 |
Nuclear Pharmacists Training and Certification |
Vol. 2 No. 6 |
427 |
Typical Day in a Nuclear Pharmacy |
Vol. 2 No. 6 |
428 |
Prescription Preparation in a Nuclear Pharmacy: Three Case Studies |
Vol. 2 No. 6 |
429 |
A Postsclerotherapy Discoloration Treatment |
Vol. 2 No. 6 |
432 |
Topical Ketoprofen for Fibromyalgia |
Vol. 2 No. 6 |
433 |
Amphotericin B 40-mg Vaginal Suppositories |
Vol. 2 No. 6 |
436 |
Beeswax Lip Balm with Sunscreen |
Vol. 2 No. 6 |
437 |
Buffered Aspirin 500-mg Capsules (Lactose Free) |
Vol. 2 No. 6 |
438 |
Dimercaptosuccinic Acid 100-mg capsules |
Vol. 2 No. 6 |
439 |
Dimercaptosuccinic Acid 100-mg/5-mL Suspension |
Vol. 2 No. 6 |
440 |
Oil and Alcohol Topical Vehicle (Preservative Free) |
Vol. 2 No. 6 |
441 |
Progesterone 200-mg/mL in Grapeseed-Oil Suspension |
Vol. 2 No. 6 |
442 |
Sertraline 7.5-mg Capsules |
Vol. 2 No. 6 |
443 |
Tannic Acid Cleaning Liquid |
Vol. 2 No. 6 |
444 |
Triple Estrogen 2.5-mg Capsules (Lactose Free) |
Vol. 2 No. 6 |
445 |
Triclosan Dental Floss: Winner-IJPC Formulations Contest, Mark Brandon Henegar |
Vol. 2 No. 6 |
446 |
Gelatin, Featured Excipient: |
Vol. 2 No. 6 |
450 |
Calculations |
Vol. 2 No. 6 |
453 |
Environmental Compounding |
Vol. 2 No. 6 |
454 |
Comparison of Job Satisfaction for Compounders and Noncompounders |
Vol. 2 No. 6 |
455 |
Chemical Stability of Meperidine Hydrochloride in Polypropylene Syringes |
Vol. 2 No. 6 |
463 |
Stability of Sufentanil in a Syringe Pump Under Simulated Epidural Infusion |
Vol. 2 No. 6 |
466 |